Akorn Inc (NASDAQ:AKRX) - Share price - Overview

Stock Report

Akorn Inc AKRX

Last Price
$13.70

Day Change
-0.03|-0.22%

As of 23/05/2018
17:07:19 EDT | USD
Minimum 15 Minutes Delay.

Last Close13.73
Day Range13.66 - 14.34
Mkt Cap1.72Bil
52-Wk Range10.76 - 33.95
Yield %-
ISINUS0097281069
Volume1,925,920
P/E-18.03
P/S2.22
P/CF18.80

Share Price

Financials
201520162017
More ...
Income Statement
Revenue985.081,116.84841.05
Operating Income326.83368.4575.12
Net Income150.80184.24-24.55
Basic EPS1.291.50-0.20
Avg. Diluted Shares Outstanding126126125
Balance Sheet
Current Assets751.16685.81730.15
Non Current Assets1,361.551,287.911,179.36
Total Assets2,112.711,973.721,909.51
Current Liabilities231.51175.56171.09
Total Liabilities---
Total Equity621.57819.18831.25
Cash Flow
Operating Cash Flow297.65167.76249.26
Capital Expenditure-31.77-78.89-95.37
Free Cash Flow265.8888.87153.89

In millions, except "Basic EPS". Currency is USD.

Company Profile

Akorn Inc is a United States based generic pharmaceutical company. It develops, manufactures and markets generic and branded prescription pharmaceuticals as well as private-label over-the-counter consumer health products and animal health pharmaceuticals.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

2,308
Key Stats
More ...
Price/Earning TTM-18.07
Price/Book2.12
Price/Sales TTM2.04
Rev Growth (3 year avg)12.35
EPS Growth (3 year avg)-
Operating Margin % TTM8.93
Net Margin % TTM-2.92
ROE TTM-2.98
Debt/Equity0.98
Dividends
PreviousLatest
More ...
Declared Date09/03/9119/03/91
Ex-Div22/03/9124/05/91
Paid15/04/9101/07/91
Amnt0.020.02
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.